Literature DB >> 22071320

Aryl hydrocarbon receptor modulation of estrogen receptor α-mediated gene regulation by a multimeric chromatin complex involving the two receptors and the coregulator RIP140.

Zeynep Madak-Erdogan1, Benita S Katzenellenbogen.   

Abstract

Although crosstalk between aryl hydrocarbon receptor (AhR) and estrogen receptor α (ERα) is well established, the mechanistic basis and involvement of other proteins in this process are not known. Because we observed an enrichment of AhR-binding motifs in ERα-binding sites of many estradiol (E2)-regulated genes, we investigated how AhR might modulate ERα-mediated gene transcription in breast cancer cells. Gene regulations were categorized based on their pattern of stimulation by E2 and/or dioxin and were denoted E2-responsive, dioxin-responsive, or responsive to either ligand. ERα, AhR, aryl hydrocarbon receptor translocator, and receptor interacting protein 140 (RIP140) were recruited to gene regulatory regions in a gene-specific and E2/dioxin ligand-specific manner. Knockdown of AhR markedly increased the expression of ERα-mediated genes upon E2 treatment. This was not attributable to a change in ERα level, or recruitment of ERα, phosphoSer5-RNA Pol II, or several coregulators but rather was associated with greatly diminished recruitment of the coregulator RIP140 to gene regulatory sites. Changing the cellular level of RIP140 revealed coactivator or corepressor roles for this coregulator in E2- and dioxin-mediated gene regulation, the choice of which was determined by the presence or absence of ERα at gene regulatory sites. Coimmunoprecipitation and chromatin immunoprecipitation (ChIP)-reChIP studies documented that E2- or dioxin-promoted formation of a multimeric complex of ERα, AhR, and RIP140 at ERα-binding sites of genes regulated by either E2 or dioxin. Our findings highlight the importance of cross-regulation between AhR and ERα and a novel mechanism by which AhR controls, through modulating the recruitment of RIP140 to ERα-binding sites, the kinetics and magnitude of ERα-mediated gene stimulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22071320      PMCID: PMC3262852          DOI: 10.1093/toxsci/kfr300

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  50 in total

1.  Genome-wide analysis of estrogen receptor binding sites.

Authors:  Jason S Carroll; Clifford A Meyer; Jun Song; Wei Li; Timothy R Geistlinger; Jérôme Eeckhoute; Alexander S Brodsky; Erika Krasnickas Keeton; Kirsten C Fertuck; Giles F Hall; Qianben Wang; Stefan Bekiranov; Victor Sementchenko; Edward A Fox; Pamela A Silver; Thomas R Gingeras; X Shirley Liu; Myles Brown
Journal:  Nat Genet       Date:  2006-10-01       Impact factor: 38.330

2.  Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters.

Authors:  Jason Matthews; Björn Wihlén; Jane Thomsen; Jan-Ake Gustafsson
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

3.  Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors.

Authors:  Zeynep Madak-Erdogan; Karen J Kieser; Sung Hoon Kim; Barry Komm; John A Katzenellenbogen; Benita S Katzenellenbogen
Journal:  Mol Endocrinol       Date:  2008-07-10

4.  ER alpha-AHR-ARNT protein-protein interactions mediate estradiol-dependent transrepression of dioxin-inducible gene transcription.

Authors:  Timothy V Beischlag; Gary H Perdew
Journal:  J Biol Chem       Date:  2005-04-18       Impact factor: 5.157

5.  Nuclear receptor coactivator SRC-1 interacts with the Q-rich subdomain of the AhR and modulates its transactivation potential.

Authors:  M B Kumar; G H Perdew
Journal:  Gene Expr       Date:  1999

6.  The aryl hydrocarbon receptor mediates degradation of estrogen receptor alpha through activation of proteasomes.

Authors:  Mark Wormke; Matthew Stoner; Bradley Saville; Kelcey Walker; Maen Abdelrahim; Robert Burghardt; Stephen Safe
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

7.  The silencing mediator of retinoic acid and thyroid hormone receptors can interact with the aryl hydrocarbon (Ah) receptor but fails to repress Ah receptor-dependent gene expression.

Authors:  S Renée Rushing; Michael S Denison
Journal:  Arch Biochem Biophys       Date:  2002-07-15       Impact factor: 4.013

Review 8.  AhR acts as an E3 ubiquitin ligase to modulate steroid receptor functions.

Authors:  Fumiaki Ohtake; Yoshiaki Fujii-Kuriyama; Shigeaki Kato
Journal:  Biochem Pharmacol       Date:  2008-09-16       Impact factor: 5.858

9.  Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype.

Authors:  Jonna Frasor; Jeanne M Danes; Barry Komm; Ken C N Chang; C Richard Lyttle; Benita S Katzenellenbogen
Journal:  Endocrinology       Date:  2003-07-10       Impact factor: 4.736

10.  Constitutive regulation of CYP1B1 by the aryl hydrocarbon receptor (AhR) in pre-malignant and malignant mammary tissue.

Authors:  Xinhai Yang; Sandra Solomon; Lauren R Fraser; Anthony F Trombino; Donghui Liu; Gail E Sonenshein; Eli V Hestermann; David H Sherr
Journal:  J Cell Biochem       Date:  2008-05-15       Impact factor: 4.429

View more
  17 in total

Review 1.  Aryl hydrocarbon receptor ligands in cancer: friend and foe.

Authors:  Iain A Murray; Andrew D Patterson; Gary H Perdew
Journal:  Nat Rev Cancer       Date:  2014-12       Impact factor: 60.716

2.  Novel roles for ERK5 and cofilin as critical mediators linking ERα-driven transcription, actin reorganization, and invasiveness in breast cancer.

Authors:  Zeynep Madak-Erdogan; Rosa Ventrella; Luke Petry; Benita S Katzenellenbogen
Journal:  Mol Cancer Res       Date:  2014-02-06       Impact factor: 5.852

3.  Endocrine disruptors fludioxonil and fenhexamid stimulate miR-21 expression in breast cancer cells.

Authors:  Yun Teng; Tissa T Manavalan; Chuan Hu; Svjetlana Medjakovic; Alois Jungbauer; Carolyn M Klinge
Journal:  Toxicol Sci       Date:  2012-10-10       Impact factor: 4.849

4.  Indole-3-carbinol and its N-alkoxy derivatives preferentially target ERα-positive breast cancer cells.

Authors:  Joseph A Caruso; Rody Campana; Caimiao Wei; Chun-Hui Su; Amanda M Hanks; William G Bornmann; Khandan Keyomarsi
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 5.  The role of lipoxin A4 in endometrial biology and endometriosis.

Authors:  G O Canny; B A Lessey
Journal:  Mucosal Immunol       Date:  2013-03-13       Impact factor: 7.313

6.  A polycyclic aromatic hydrocarbon-enriched environmental chemical mixture enhances AhR, antiapoptotic signaling and a proliferative phenotype in breast cancer cells.

Authors:  Larisa M Gearhart-Serna; John B Davis; Mohit Kumar Jolly; Nishad Jayasundara; Scott J Sauer; Richard T Di Giulio; Gayathri R Devi
Journal:  Carcinogenesis       Date:  2020-12-31       Impact factor: 4.944

Review 7.  Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target.

Authors:  Stephen Safe; Syng-Ook Lee; Un-Ho Jin
Journal:  Toxicol Sci       Date:  2013-06-14       Impact factor: 4.849

8.  Estrogen receptor-α and aryl hydrocarbon receptor involvement in the actions of botanical estrogens in target cells.

Authors:  Ping Gong; Zeynep Madak-Erdogan; Jodi A Flaws; David J Shapiro; John A Katzenellenbogen; Benita S Katzenellenbogen
Journal:  Mol Cell Endocrinol       Date:  2016-08-16       Impact factor: 4.102

9.  Pressure regulated basis for gene transcription by delta-cell micro-compliance modeled in silico: Biphenyl, bisphenol and small molecule ligand models of cell contraction-expansion.

Authors:  Hemant Sarin
Journal:  PLoS One       Date:  2020-10-06       Impact factor: 3.240

Review 10.  Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma.

Authors:  Yunli Zhou; Xun Zhang; Anne Klibanski
Journal:  Mol Cell Endocrinol       Date:  2013-09-11       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.